Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Corp. Common Shares (NY: ZOM )

0.1239 -0.0005 (-0.40%)
Official Closing Price Updated: 4:10 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zomedica Corp. Common Shares

< Previous 1 2 3 4 5 6 Next >
Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health
Zomedica Corp (AMEX: ZOM) launches 2 new canine assays for its TRUFORMA platform. NT-proBNP test detects heart failure, progesterone test helps with breeding timing. 
Via Benzinga
Zomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA Reach
Zomedica expands partnership with Grovet to distribute equine products in 27 European countries, including Germany, France, and Spain. 
Via Benzinga
More Than $9M Bet On Nerdy? Check Out These 3 Penny Stocks Executives Are Aggressively Buying
Via Benzinga
ZOM Stock Earnings: Zomedica Misses Revenue for Q2 2024
ZOM stock results show that Zomedica missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Zomedica Taps Into Costa Rica With Strategic Partnership With SIRE Veterinario
Zomedica Corp. expands into Costa Rica with SIRE Veterinario as exclusive distributor. Strategic partnership aims to bring advanced veterinary solutions to local veterinarians. 
Via Benzinga
7 ‘Lottery Ticket Stocks’ That Could Turn $1K into $10K
Aggressive investors take note: these seven high-risk. high-reward stocks have the potential to rise in value by as much as 1,000%. 
Via InvestorPlace
ZOM Stock Earnings: Zomedica Misses Revenue for Q1 2024
ZOM stock results show that Zomedica missed on revenue for the first quarter of 2024. 
Via InvestorPlace
ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023
ZOM stock results show that Zomedica beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
The 3 Most Undervalued Penny Stocks to Buy in June 2024
Numerous penny stocks are undervalued and might benefit from elevated trading activity, given their fundamental zeal. 
Via InvestorPlace
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
Via Benzinga
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning! 
Via InvestorPlace
Why Shares of Zomedica Were Zooming Monday
Investors bought back into the stock after it fell to its lowest point in two months. 
Via The Motley Fool
Earnings Scheduled For April 1, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. 
Via Benzinga
3 High-Reward Penny Stocks to Uncover Big Gains
Dive into the realm of high-reward penny stocks. The article gives the insights you need to spot quality plays and make informed decisions. 
Via InvestorPlace
7 Penny Stocks to Buy on the Dip: February 2024
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks. 
Via InvestorPlace
3 Hidden-Gem Penny Stocks That Could Yield Life-Changing Wealth
Unlock the secret to wealth with insights on ZOM, SNDL, and BLDE. Discover how these penny stocks could redefine your future. 
Via InvestorPlace
3 Breakout Penny Stocks Primed for Massive Gains
Discover three penny stocks poised for breakout success in veterinary, liquor retail, and insurance sectors. 
Via InvestorPlace
Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth
These cheap stocks offer investors an extreme risk to reward tradeoff, which might be worth considering for lucrative payoffs. 
Via InvestorPlace
7 Biotech Stocks to Sell in September Before They Crash & Burn
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues. 
Via InvestorPlace
The 7 Most Promising Penny Stocks to Buy in May 2023
Although extremely low-priced securities often present high risk, these are the most promising penny stocks to buy in May. 
Via InvestorPlace
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Earnings Scheduled For May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... 
Via Benzinga
7 Small-Cap Biotech Stocks with Massive Potential
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical. 
Via InvestorPlace
7 Best Penny Stocks Under $3 to Buy in April
If you have the audacity to consider ultra-speculative opportunities, these ideas for best penny stocks under $3 might be appealing. 
Via InvestorPlace
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
PRTY Stock Alert: NYSE Halts Trading in Party City Amid Bankruptcy News
Party City (PRTY) stock halted trading this morning after the retail company filed for Chapter 11 bankruptcy protection. 
Via InvestorPlace
Why Is Zomedica (ZOM) Stock Up Today?
Zomedica (ZOM) stock is on the rise Wednesday after the company signed a strategic restructuring agreement with Qorvo Biotechnologies. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.